Friday, June 19, 2026
IPEC Annual Meeting pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED

IPEC Annual Meeting — 2026 — Gaylord Opryland Resort & Convention Center, Nashville, United States

Excipient World is the ONLY U.S. event focused exclusively on excipients. Our mission is to present cutting-edge scientific developments, formulation and technology advancements, quality production and the safe use of excipients, as well as regulatory mandates to better address t

Gaylord Opryland Resort & Convention Center, Nashville, United States May 4 – May 6, 2026
2 Presentations
All Events

Presentation data updated Jun 17, 2026, 5:36 AM UTC

Why This Event Matters

Excipient World is the ONLY U.S.

Industry impact

Excipient World is the ONLY U.S.

Market implications

Expect signals on pricing, formulary strategy, and partnership economics relevant to general markets in the US region.

Regulatory implications

FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at general leadership forums.

Investor implications

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from IPEC Annual Meeting.

Competitive implications

Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Event Significance

Tier-1 industry catalyst

54 /100 composite

IPEC Annual Meeting is a targeted general forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: downstream media and analyst follow-through.

  • Media coverage 20/20

    High follow-on media and sell-side note volume expected within 24–48h of key sessions.

  • Speaker quality 14/20

    Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.

  • Pipeline relevance 0/20

    Early science or services-focused — lower near-term PDUFA linkage.

  • Historical influence 20/20

    Prior editions moved stock prices and label expansions — expect similar volatility windows.

  • Company participation 0/20

    Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.

Nova Pharma Intelligence · Analyst desk

Key Takeaways

  • Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from IPEC Annual Meeting.
  • FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at general leadership forums.

Timeline & Milestones

  1. Pre-event intelligence Complete

    2 presentations tracked — Key Data and Companies hubs live.

  2. Conference opens May 4, 2026 Complete

    Live readouts, late-breakers, and partnership announcements.

  3. Live coverage window Complete

    4 Nova articles linked — see Coverage & Analysis.

  4. Conference closes May 6, 2026 Complete

    Post-event recap, competitive takeaways, and trial updates.

Best for
Investors & analysts

Executive Summary

C-level brief

Excipient World is the ONLY U.S.

Primary audience: Investors & analysts

Analyst Watch

Investor desk

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from IPEC Annual Meeting.

Regulatory affairs

FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at general leadership forums.

Competitive intelligence

Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Most Anticipated Presentations

Full data hub →
LATE-BREAKER

MDA Late-Breaking Abstract Portal (different event, not IPEC)

INVESTOR IMPACT: ★★☆☆☆ 2/5
POSTER

Poster Abstracts for Excipient World Conference & Expo 2026 (no specific title available)

Competitive Landscape

Company map →

Competitive positioning among top general players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Coverage & Analysis

3 articles

Related News & Research

Research hub →

Event Intelligence Summary

Standalone summaries for IPEC Annual Meeting — optimized for research and AI retrieval.

Executive Summary

Excipient World is the ONLY U.S.

Analyst View

Excipient World is the ONLY U.S.

Investor View

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from IPEC Annual Meeting.

BD View

BD teams should prioritize networking with presenting companies and services vendors at IPEC Annual Meeting, focusing on general partnership and licensing opportunities.

Key Facts

Event
IPEC Annual Meeting
Focus
general
Region
US Americas

Ask Nova AI

AI-assisted answers grounded in NovaPharmaNews intelligence

Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.

Frequently Asked Questions

What is IPEC Annual Meeting?

IPEC Annual Meeting is a general industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.

Who attends IPEC Annual Meeting?

Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on general.

Why is IPEC Annual Meeting important?

IPEC Annual Meeting influences partnership timing, pipeline prioritization, and policy debates that affect general markets for the next 12–18 months.

When is IPEC Annual Meeting?

IPEC Annual Meeting takes place on the scheduled dates.

Where is IPEC Annual Meeting held?

IPEC Annual Meeting is held in the listed venue.

What should investors watch at IPEC Annual Meeting?

Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on general catalysts during and after IPEC Annual Meeting.

What BD opportunities exist at IPEC Annual Meeting?

BD teams use IPEC Annual Meeting for licensing discussions, co-development talks, and vendor selection across general — especially in networking sessions and satellite meetings.

How does IPEC Annual Meeting compare with other pharma conferences?

IPEC Annual Meeting is a tier-1 global congress for general — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.

How do I get NovaPharmaNews coverage of IPEC Annual Meeting?

NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for IPEC Annual Meeting. Subscribe to event alerts on this page for breaking updates.

Intelligence Navigation